Did you know that ADHD has nearly doubled over the last generation to now include more than 10 percent of U.S. children and adolescents? Between 1997-1999 and 2014-2016 the prevalence of the diagnosis increased significantly across age, gender, race/ethnicity, income and geography. These are results from U.S. national survey data collected by the National Center for Health Statistics within the Centers for Disease Control and Prevention.1
There are a few possible reasons for this increase. For one, the criteria that the scientific community uses for diagnosing ADHD has broadened over the last two decades. In the past, you had to be diagnosed as having, or at least have had significant impairment, prior to the age of 7. Now under DSM-52, only several inattentive or hyperactive-impulsive behaviors must be identified prior to age 12. Also, there have been changes in the diagnostic criteria; there is now recognition of the differences in how behaviors may manifest themselves in children vs adolescents and adults. Finally, there’s overall less stigma and more access to medical care, which has broadened the population being captured.
How ADHD is addressed has also changed during this same time frame. Today, ADHD management is usually multi-factorial, including pharmacological medications, behavioral therapy, education and nutritional changes. Since 2011, Vayarin® and Vayarin® Plus have also come on the scene. Vayarin® (for children) and Vayarin® Plus (for adults and adolescents) are medical foods containing EPA-enriched PS-Omega-3 that is specially formulated with nutritional ingredients that are naturally sourced and have virtually no difference in side effects when compared to placebo. Both products help to manage the lipid imbalances known to be present in ADHD and can improve attention and emotional regulation.
Although individual results may vary, give Vayarin® 30-90 days and Vayarin® Plus 30-60 days for the healthy lipids to reach optimal levels. Once they have reached their optimal level both products provide 24/7 coverage, unlike many stimulants which can wear off after each dose. Talk to your healthcare provider about Vayarin® or Vayarin® Plus today.
The past two decades have seen many changes in how ADHD is diagnosed and managed. A balanced approach to managing this difficult condition can help individuals feel focused and well-equipped to take on an ever-changing world.
 See, Health, United States, 2017, National Center for Health Statistics, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services (2017) at p. 6; accessible at: https://www.cdc.gov/nchs/data/hus/hus17.pdf
 The American Psychiatric Association’s “Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition,” published in 2013.